Načítá se...
Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks
To escape replicative senescence, cancer cells have to overcome telomere attrition during DNA replication. Most of cancers rely on telomerase to extend and maintain telomeres, but 4–11% of cancers use a homologous recombination-based pathway called alternative lengthening of telomeres (ALT). ALT is...
Uloženo v:
| Vydáno v: | Cell Biosci |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063710/ https://ncbi.nlm.nih.gov/pubmed/32175073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00391-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|